NEW YORK, Jan. 16 /PRNewswire/ -- Investment and M&A activity in the life sciences and healthcare sector is at an all-time high and expected to grow even more in 2008. CEOs, CFO's and other business executives from pharmaceutical, biotech, medical and other life sciences companies will be joined by some of the most sophisticated investors in the industry at the 2008 Investment and M&A Opportunities in Healthcare, April 30-May 1, 2008, in Chicago.
Deal volume in the healthcare sector in October 2007 surged to its
highest month level ever. A total of 102 deals -- with over $14.0 billion
in commitments -- is evidence that investment and M&A activity in the
healthcare space will be robust in 2008 and beyond:
Medical Devices: 20 Deals in October 2007
Biotechnology: 19 Deals in October 2007
Pharmaceuticals: 19 Deals in October 2007
In 2005, there were 33 such deals amounting to $16.5 billion, while in
the first 9 months of 2007, 49 deals totaling $28.7 billion were
consummated. Financial buyers, led by private equity, hedge funds and other
investors are also continuing to play a big role in this space.
Preliminary speaking faculty includes:
-- Donald Adam, Senior VP & Chief Development Officer, RehabCare Group
Inc.
-- Christine Arakelian, VP, Business Development, Omnicare
-- Bill Baker, Partner, KPMG LLP, Transaction Services
-- Andy Bressler, Managing Director, Banc of America Securities
-- Jay Dennis, VP, Technology, IBM Corporation
-- Steven Elek, III, Leader, Healthcare Transaction Services,
PricewaterhouseCoopers
-- David Ertel, Managing Director, Morgan Stanley
-- Bob Funari, CEO, Crescent Healthcare
-- Matthew Gallivan, President, Nashville Health Care Council
-- Scott Kozicki, Founder & CEO, Truu Health, Inc.
-- Philip A. Borden, Principal, Riverside Partners
-- Geoffrey Ligibel, CFA, VP, Healthcare Group, Houlihan Lokey
-- Burk Lindsay, Senior VP, Healthcare Banking Practice, Raymond James
-- Michael O'Neil, VP, Strategic Initiatives, HealthSpring
-- Tim Petrikin, CEO, e+healthcare
-- Don Rupprecht, Integration Partner, PricewaterhouseCoopers
-- Franklin M. Stokes, Managing Director, Robert W. Baird Healthcare
Investment Banking
-- Lambert van der Walde, Capital Markets Advisor to the Administrator,
Center for Medicaid & Medicare Service, U.S. Department of Health &
Human Services
-- Nathaniel M. Zilkha, Principal, Healthcare Investing Group, Kohlberg
Kravis Roberts & Co.
Don Buford
CEO
International Institute for Business Information & Growth (iiBIG)
Phone: 212-300-2521
E-mail: donb@iibig.com
'/>"/>
| SOURCE iiBIG Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. 500-Plus Animals Part of the Team at Healthcare Organization
2. HealthCare.com & MediResource Partner to Distribute and License Health Content, Directory and Tools
3. Dr. Bart Harmon Named Chief Medical Officer for Harris Corporations Healthcare Solutions Business
4. Virginia Cares Uninsured Program (VCUP) Announces Early Successes in Helping Uninsured Virginians Access Quality Healthcare
5. Sedgwick CMS Expands Healthcare Professional Liability Claims Services in Investigations, Risk Management, Audit & Consulting
6. Assurant Health Gains Access to Great-West Healthcares Nationwide Network
7. Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team
8. Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector
9. Advanced Home Care Extends Its Use of Authentidates Inscrybe(TM) Healthcare Platform
10. Statement From the Consumer Healthcare Products Association on the SAMHSA Findings on Cough Medicine Abuse
11. Shimp Joins Pinstripe as Director of Client Services for Healthcare Group
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |